Pay in 4 interest-free payments of $8.00 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
PF-4136309 is not a cytochrome P450 (CYP) inhibitor
Tyler Lahusen
NVP-231 (1 μM
Treatment with AMD3100 at any concentration (10
an ATR substrate
ETC-159 - CAS# 1638250-96-0 210 PF-4136309 is not a cytochromeETC 159, CAS No. 1638250 96 0, also known as ETC 1922159, is a potent, selective and orally available PORCN inhibitor. ETC 159 blocks the secretion and activity of all Wnts. ETC 159 is remarkably effective in treating RSPO translocation bearing colorectal cancer (CRC) patient derived xenografts. Inhibition of Wnt signaling by PORCN inhibition holds promise as differentiation therapy in genetically defined human cancers. Enhanced sensitivity to Wnts is
US$ 35.00
US$ 30.00
US$ 50.00